SZOTKOWSKI, Tomáš, Jan MUŽÍK, Jaroslava VOGLOVÁ, V. KOZA, J. MAALOUFOVA, Tomáš KOZÁK, Marie JAROŠOVÁ, Kyra MICHALOVÁ, Pavel ŽÁK, Kateřina STEINEROVÁ, J. VYDRA, M. LÁNSKÁ, B. KATRINCSÁKOVÁ, Kateřina SIČOVÁ, Tomáš PAVLÍK, Ladislav DUŠEK and Karel INDRÁK. Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech Republic. Neoplasma. 2010, vol. 57, No 6, p. 578-589. ISSN 0028-2685.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech Republic
Authors SZOTKOWSKI, Tomáš (203 Czech Republic, guarantor), Jan MUŽÍK (203 Czech Republic, belonging to the institution), Jaroslava VOGLOVÁ (203 Czech Republic), V. KOZA (203 Czech Republic), J. MAALOUFOVA (203 Czech Republic), Tomáš KOZÁK (203 Czech Republic), Marie JAROŠOVÁ (203 Czech Republic), Kyra MICHALOVÁ (203 Czech Republic), Pavel ŽÁK (203 Czech Republic), Kateřina STEINEROVÁ (203 Czech Republic), J. VYDRA (203 Czech Republic), M. LÁNSKÁ (203 Czech Republic), B. KATRINCSÁKOVÁ (203 Czech Republic), Kateřina SIČOVÁ (203 Czech Republic), Tomáš PAVLÍK (203 Czech Republic, belonging to the institution), Ladislav DUŠEK (203 Czech Republic, belonging to the institution) and Karel INDRÁK (203 Czech Republic, belonging to the institution).
Edition Neoplasma, 2010, 0028-2685.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.449
RIV identification code RIV/00216224:14710/10:00051571
Organization unit Institute of Biostatistics and Analyses
UT WoS 000286494400012
Keywords in English Acute myeloid leukemia; prognostic factors; consolidation; stem cell transplantation; treatment outcome; registry
Tags International impact, Reviewed
Changed by Changed by: RNDr. Tomáš Pavlík, Ph.D., učo 52483. Changed: 18/4/2012 10:38.
Abstract
Acute myeloid leukemia (AML) is a severe condition with a high mortality. When making decisions about the optimal tailor-made therapy, numerous prognostic factors are considered. The study represents a detailed analysis of the role of these factors and treatment outcomes based on a long-term follow-up of patients treated in 5 hematology intensive care centers in the Czech Republic.
PrintDisplayed: 9/5/2024 06:58